Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modified Neisseria meningitidis strains of immunotype L6

Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modified Neisseria meningitidis strains of immunotype L6

US Patent 10137145 · Granted Nov 27, 2018

Estimated economic value: $5,367,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions for use in treatment of acne2025
Meningococcal B recombinant vaccine2024
Immunogenic compositions against S. aureus2020
Immunogenic compositions against S. aureus2020
Compositions comprising N. meningitidis proteins2019
Compositions comprising N. meningitidis proteins2019
Compositions comprising N. meningitidis proteins2019
Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modifi2017
Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modifi2017
Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modifi2017
Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modifi2017
Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modifi2015